Editorial: Monitoring methotrexate polyglutamates in Crohn's disease
- PMID: 38085937
- DOI: 10.1111/apt.17743
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease
Comment in
-
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease-Authors' reply.Aliment Pharmacol Ther. 2024 Jan;59(1):120-121. doi: 10.1111/apt.17795. Aliment Pharmacol Ther. 2024. PMID: 38085943 No abstract available.
Comment on
-
Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.Aliment Pharmacol Ther. 2023 Dec;58(11-12):1151-1162. doi: 10.1111/apt.17719. Epub 2023 Sep 28. Aliment Pharmacol Ther. 2023. PMID: 37767910
References
REFERENCES
-
- Dervieux T, Furst D, Lein DO, Capps R, Smith KM, Caldwell J, et al. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study. Ann Rheum Dis. 2005;64:1180-1185.
-
- Stamp LK, O'Donnell JL, Chapman PT, Zhang M, James J, Frampton C, et al. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis Rheum. 2010;62(2):359-368.
-
- Brooks AJ, Begg EJ, Zhang M, Frampton CM, Barclay ML. Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease. Ther Drug Monit. 2007;29(5):619-625.
-
- Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Frampton C, James J, et al. Determinants of red blood cell methotrexate polyglutamate concentrations in patients with rheumatoid arthritis on long-term MTX. Arthritis Rheum. 2009;60(8):2248-2256.
-
- van de Meeberg MM, Fidder HH, Bas O, Sundaresan J, Struys EA, Montazeri NSM, et al. On behalf of the Dutch initiative on Crohn and colitis (ICC). Therapeutic drug monitoring of methotrexate in patients with Crohn's disease. Aliment Pharmacol Ther. 2023; 58:1151-1162.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical